ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

APH Alliance Pharma Plc

33.70
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Alliance Pharma Plc LSE:APH London Ordinary Share GB0031030819 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 33.70 33.70 33.85 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 167.42M 936k 0.0017 198.24 182.03M
Alliance Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker APH. The last closing price for Alliance Pharma was 33.70p. Over the last year, Alliance Pharma shares have traded in a share price range of 33.45p to 72.60p.

Alliance Pharma currently has 540,150,223 shares in issue. The market capitalisation of Alliance Pharma is £182.03 million. Alliance Pharma has a price to earnings ratio (PE ratio) of 198.24.

Alliance Pharma Share Discussion Threads

Showing 801 to 821 of 3225 messages
Chat Pages: Latest  33  32  31  30  29  28  27  26  25  24  23  22  Older
DateSubjectAuthorDiscuss
25/11/2010
21:48
Growth will probably come from buying more companies or tablets.

They have a new facility now of 20 million +, which i assume they will put to good use.

stegrego
25/11/2010
20:34
Could be Phonics - but the company have signalled this for quite a while and I would have thought it was already priced in....anyway it is now!

Silverfern - whilst Deltracortil sales will certainly stall, were you referencing other products as well and if so which?

melody9999
24/11/2010
09:41
Unfortunately it looks like the monopoly alliance had on their leading drug deltracortil is about to come to an end:



Perhaps that's part of the reason behind the recent drop off

phonics
23/11/2010
07:40
Steg: is that a statistic you can justify :) I invested heavily in APH early in the year between 25-30p. The current price represents a significant gain on that range given the prevailing economy. Within APH's portfolio are products whose market growth is stalling. I have no doubt they are very well run and have performed brilliantly in the last two years but where does anyone here see growth coming from to sustain or push the market cap higher?
silverfern
22/11/2010
21:25
The share price struggles every time they make a CULS conversion, as i think the shares are sold into the market.

However, this is a great medium term bet and much more likely to come up with the goods than some dodgy oufit drilling for something in the back of beyond...

stegrego
22/11/2010
20:54
Hence my leaving - Melody it would be v useful if you would provide a technical basis for your contention.
silverfern
22/11/2010
12:35
Yeah - suspect some money leaving to join faster moving stocks - especially in resources. I like to keep a nice balance portfolio and nothing to suggest that trading for APH continues to be anything but positive. We may get chance to add a few more.
melody9999
22/11/2010
10:56
Going away from that 50p melody.Shame it broke that 36p line.Still we may get an update in December.
shauney2
07/11/2010
17:40
hmmm - looks like time for a break out here - I'm fully committed but looking at the graph I can see 50p coming quite quickly.
melody9999
15/10/2010
12:05
SMART INVESTOR1: Thanks for that useful link. I've been investing for 40 years and am still a novice :-(
sandbank
02/10/2010
08:43
RHPS upped it's buy limit to 39p which may bring a few more in next week.

DC

daicaprice
27/9/2010
11:06
Thanks - also check out the Sept2010 presentation on the co's website:
It mentions Forceval and China! but worth a read anyway, espcially if any readers are here because of MOney Week.

silverfern
26/9/2010
19:49
Tipped in Money Week. It states that only 5% of the companies sales come from China. However, the firms small size means that any slight growth in Chinese volumes will have a pronounced effect on the price. The firm is relitivley cheap on a forward p/e of 11.
Article was looking at future winners as the Chinese increase spending on healthcare. Also tipped Synergy Health SYR,
I did not realise that even 5% of sales went to China.

rogerbridge
19/9/2010
00:04
Matt - can you tell where you have read about an earnings drop? A drop in rate of growth maybe , but still increasing EPS as far as I am aware.
melody9999
18/9/2010
15:58
Think it's just the reality of forecast earnings drop next year.
matt
17/9/2010
16:42
Agree silver.Frustrating after the strong results but patience is the key withis one.
First had some 5 years ago around 17p and sold too early.

shauney2
17/9/2010
10:03
what a miserable market reaction so far to the results
silverfern
10/9/2010
16:32
roundup market makers matching sellar with buyer
goldie40
10/9/2010
15:21
Can anybody tell why there are so many massive sells today without the price dropping substantially.
roundup
10/9/2010
12:25
I thought from memory that this year's results include a drug that the aquisition make which the government only buy once every few years. That's why next year's forecasts are lower than this year.
matt
10/9/2010
08:48
Weird that he thinks it will do better than expected but doesn't change his profit forecast
deucetoace
Chat Pages: Latest  33  32  31  30  29  28  27  26  25  24  23  22  Older

Your Recent History

Delayed Upgrade Clock